Clinical Trials: Emphysema

Alabama

Birmingham; Cardiothoracic Surgery ,University of Alabama, Birmingham
The IBV® Valve Trial A research study for people suffering from Emphysema.

Birmingham; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Mobile; Pulmonary Associates of Mobile, PC
The IBV® Valve Trial A research study for people suffering from Emphysema.

Arizona

Phoenix; Pulmonary Associates Phoenix
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Arkansas

Little Rock; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

California

Los Angeles; UCLA David Geffen School of Medicine
The IBV® Valve Trial A research study for people suffering from Emphysema.

Los Angeles; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Los Angeles; Cedars-Sinai Medical Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Mission Viejo; Mission Internal Medicine Group
The IBV® Valve Trial. An investigational treatment for people suffering from Emphysema.

Sacramento ; UC Davis Medical Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Sacramento; UC Davis Medical Center
The IBV® Valve Trial A research study for people suffering from Emphysema.

San Diego ; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Torrance ; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Colorado

Denver; National Jewish Medical and Research Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Denver; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Florida

Panama City; Emerald Coast Research Associates
Are you a current or former smoker who has been diagnosed with emphysema or chronic bronchitis?

Sarasota; Clinical Research Center at Sarasota Memorial Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Georgia

Atlanta; Emory Healthcare
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Atlanta; The Emory Clinic, Emory University
The IBV® Valve Trial A research study for people suffering from Emphysema.

Illinois

Chicago; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Elk Grove Village; Alexian
The IBV® Valve Trial A research study for people suffering from Emphysema.

Peoria; Peoria Pulmonary Associates
The EASE Trial: An investigation of the Exhale ® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Springfield; Southern Illinois University Medical Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Winfield; Chicago Chest Center at Central DuPage Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Iowa

Iowa City; University of Iowa Hospitals and Clinics
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Kansas

Olathe; Consultants in Pulmonary Medicine
The IBV® Valve Trial A research study for people suffering from Emphysema.

Topeka; Veritas Clinical Specialties/Topeka Pulmonary
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Kentucky

Louisville; University of Louisville
The IBV® Valve Trial. An investigational treatment for people suffering from Emphysema.

Louisiana

Slidell; Medical Research Institute, Inc.
Do You Suffer From Chronic Bronchitis Or Emphysema?

Maryland

Baltimore; Pulmonary & Critical Care Associates of Baltimore
The IBV® Valve Trial. An investigational treatment for people suffering from Emphysema.

Massachusetts

Boston; Brigham and Women's Hospital (BWH)
The Effect of Chronic Macrolide Administration on the Frequency and Severity of COPD Exacerbations

Boston; Boston Medical Center
The IBV® Valve Trial. An investigational treatment for people suffering from Emphysema.

Michigan

Ann Arbor; ClinSite, LLC
7 month chronic bronchitis or emphysema (COPD) research study

Ann Arbor; ClinSite, LLC
Are you a current or former smoker who has noticed changes in your breathing?

Detroit; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Detroit; Henry Ford Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Minnesota

St.Paul; Health Partners Specialty Ctr, Lung&Sleep Health Clinic
The IBV® Valve Trial A research study for people suffering from Emphysema..

Nebraska

Omaha; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

New Jersey

Summit; Pulmonary and Allergy Associates
The IBV® Valve Trial A research study for people suffering from Emphysema.

New York

Albany; Pulmonary and Critical Care Services, P.C.
New investigational medication for COPD/Emphysema

Brooklyn; New York Methodist Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Endwell; Regional Clinical Research, Inc.
Do you have any of these problems? Shortness of Breath? Cough? Chronic Bronchitis? Emphysema? Wheezing? Phlegm? Chronic Obstructive Pulmonary Disease?

New York; New York University -- Bellevue Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

New York; New York University School of Medicine
The IBV® Valve Trial. An investigational treatment for people suffering from Emphysema.

New York; NewYork-Presbyterian/Columbia University Medical Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

New York; Mt. Sinai School of Medicine
The IBV® Valve Trial A research study for people suffering from Emphysema.

North Carolina

Charlotte; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Durham; Duke University Medical Center
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Ohio

Cleveland; Cleveland Clinic Foundation
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Cleveland; Cleveland Clinic Foundation
The IBV® Valve Trial A research study for people suffering from Emphysema.

Oklahoma

Oklahoma City; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Tulsa; Oklahoma State
The IBV® Valve Trial A research study for people suffering from Emphysema.

Pennsylvania

Allentown; Lehigh Valley Hospital
The IBV® Valve Trial A research study for people suffering from Emphysema.

Philadelphia; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Philadelphia; Hospital of the University of Pennsylvania
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

Philadelphia; University of Pennsylvania
The IBV® Valve Trial A research study for people suffering from Emphysema.

Rhode Island

Providence; Rhode Island Hospital
The IBV® Valve Trial A research study for people suffering from Emphysema.

South Carolina

Spartanburg; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Texas

Houston; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

San Antonio; Sun Research Institute
Do you have COPD? If so, you may qualify to participate in a 28 week research study.

San Antonio; Sun Research Institute
Volunteers needed for three year research study of an investigational medicine for Emphysema or Chronic Bronchitis (COPD).

Utah

Salt Lake City; University of Utah Health Sciences Center
The IBV® Valve Trial A research study for people suffering from Emphysema.

Virginia

Charlottesville; University of Virginia
The VITAL- Valve Intervention Treatment Trial

Charlottesville; University of Virginia
Hyperpolarized Helium-3 MR Lung Imaging in Patients with Chronic Obstructive Pulmonary Disease, Patients with Lung Lesions, and Healthy Volunteers. HIC #: 8973

Norfolk; Sentara Norfolk General Hospital
The EASE Trial: An investigation of the Exhale® Drug-Eluting Stent in homogeneous emphysema patients with severe hyperinflation

International

Fitzroy, Australia; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Leuven, Belgium; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Pleven, Bulgaria; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Ruse, Bulgaria; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Sofia, Bulgaria; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Toronto, ON, Canada; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Vancouver, BC, Canada; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Karlovy Vary, Czech Republic; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Ostrava, Czech Republic; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Praha, Czech Republic; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Tabor, Czech Republic; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Hellerup, Denmark; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Marburg, Germany; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Balassagyarmat, Hungary; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Budapest, Hungary; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Pecs, Hungary; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Szombathely, Hungary; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Torokbalint, Hungary; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Reykjavik, Iceland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Ashkelon, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Haifa, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Petah Tikva, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Ramat Gan, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Rehovot, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Tel Aviv, Israel; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Genova, Italy; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Modena, Italy; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Pavia, Italy; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Pisa, Italy; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Trieste, Italy; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Daugavpils, Latvia; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Riga, Latvia; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Almelo, Netherlands; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Leiden, Netherlands; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Maastricht, Netherlands; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Otahuhu, New Zealand; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Bialystok, Poland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Katowice, Poland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Lodz, Poland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Poznan, Poland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Warszawa, Poland; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Amanzimtoti, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Bellville, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Bloemfontein, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Cape Town, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Centurion, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Durban, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Worcester, South Africa; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Barakaldo, Spain; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Vigo, Spain; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Malmoe, Sweden; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Zürich, Switzerland; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Dnipropetrovs'K, Ukraine; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Donetsk, Ukraine; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Kiev, Ukraine; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Birmingham, United Kingdom; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Cambridge, United Kingdom; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)

Coventry, United Kingdom; Research Site:
TESRA: (Treatment of Emphysema with a gamma-Selective Retinoid Agonist)

Edinburgh, United Kingdom; Research Site:
REPAIR Tier 2 - (Retinoids in Emphysema Patients on the Alpha-1-Antitrypsin International Registry)